MENU
TRDA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Entrada Therapeutics (TRDA) Ownership - Who owns Entrada Therapeutics?

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more

Profile

Industry
N/A
Address
One Design Center Place
Phone
+1 857 520-9158
Employees
159
Web
https://www.entradatx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
516.84M
P/E Ratio
10.26
Total Cash
295.7M
Projected Growth
N/A
Total Debt
50.93M
Revenue
25.42M
Risk (Beta)
0.98
Dividend Yield
N/A
Total Cash/Share
7.72
Total Debt/Equity
N/A
Revenue/Share
0.61 USD as % of share price

Fundamentals

TRDA
Capitalization
517M
P/E Ratio
10.26
Risk (Beta)
0.98
Dividend Yield
N/A
Total Cash
296M
Total Cash/Share
7.72
Total Debt
50.9M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.61%
Revenue
25.4M
ROE
N/A
Book Value
306M
P/B Ratio
1.69
Cash Flow
N/A
Earnings
-3.47
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
4K
Current Ratio
12.53
Current Revenue Per Employee
7098.36
Dividends Per Share - Security
N/A
EBITDA
-153.8M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-31.81
Shares Held By Institutions
324M
Shares Outstanding - Current
38.3M
Total Liabilities
71.2M
Total Volume MTD
N/A
Value
N/A
Gain YTD
31.323
View a ticker or compare two or three
TRDA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. TRDA showed earnings on February 26, 2026. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
One Design Center Place
Phone
+1 857 520-9158
Employees
159
Web
https://www.entradatx.com